RecruitingNCT05550077

Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis

Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis: a Prospective Registry Study (OCT-ICAS)


Sponsor

jiaoliqun

Enrollment

400 participants

Start Date

Mar 15, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Optical Coherence Tomography and a procedure called Percutaneous transluminal angioplasty and stenting for people with artery stenosis, intracranial atherosclerosis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTOptical Coherence Tomography

Intravascular evaluation for vessel wall structure of intracranial atherosclerotic stenosis by application of optical coherence tomography

PROCEDUREPercutaneous transluminal angioplasty and stenting

Percutaneous transluminal angioplasty and stenting will be performed follow the standard or adjusted according to OCT evaluation.


Locations(1)

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05550077


Related Trials